Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan 26;90(2):393-6.
doi: 10.1038/sj.bjc.6601548.

Breast density as a determinant of interval cancer at mammographic screening

Affiliations

Breast density as a determinant of interval cancer at mammographic screening

S Ciatto et al. Br J Cancer. .

Abstract

The association of breast density (% of breast volume involved by fibro-glandular densities) with the risk of interval cancer (IC) was investigated by reviewing a consecutive series of 346 cancers detected at screening (SDC) during 1996-1999 and of 90 ICs, reported as negative in the same period and diagnosed in the following 2 years, and comparing them to a random sample of 360 healthy controls. The probability of IC was significantly associated with breast density, whatever grouping (0/1-25/26-74/>74%; 0-25/26-60/61-74/>74%; 0-25/26-74/>74%) was considered (chi(2)=30.67-34.08, P<0.<0.01): 27.8% of all ICs were classified in the >74% density class, as compared to 7% of SDC and 5% of healthy controls. No significant association to IC was observed for Wolfe pattern (P2/Dy vs N1/P1: chi(2)=0.30, P=0.960), number of used mammographic views (single oblique vs oblique+craniocaudal: chi(2)=0.02, P=0.90) or screening round (first vs repeat: chi(2)=1.41, P=0.23). Multivariate analysis confirmed the independent association of breast density to IC, the highest risk being observed for >74% density class (OR vs 0% class=13.4, 95% CI 2.7-65.6, OR vs all other density classes=5.1, 95% CI 2.6-10.0). Age showed an independent association too, older women having a lower risk of IC (OR=0.52 95% CI 0.3-09). Breast density (>74%) resulted as being a major determinant of IC. Special screening protocols (shorter rescreening interval, routine use of ultrasonography) might be suggested for these subjects in order to improve screening sensitivity and efficacy.

PubMed Disclaimer

References

    1. Berkowitz JE, Gatewood OMB (1990) Hormonal replacement therapy: mammographic manifestations. Radiology 174: 199–201 - PubMed
    1. Bryan S, Brown J, Warren R (1995) Mammography screening: an incremental cost effectiveness analysis of two views versus one view procedures in London. J Epidemiol Commun Health 49: 70–78 - PMC - PubMed
    1. Ciatto S, Bonardi R, Zappa M (2001) Effects of hormone replacement therapy on the mammographic density of postmenopausal women undergoing screening mammography. Radiol Med 101: 39–43 - PubMed
    1. Ciatto S, Rosselli Del Turco M, Morrone D, Catarzi S, Ambrogetti D, Cariddi A, Zappa M (1995a) Independent double reading of screening mammograms. J Med Screen 2: 99–101 - PubMed
    1. Ciatto S, Rosselli Del Turco M, Zappa M (1995b) The detectability of breast cancer by screening mammography. Br J Cancer 71: 337–339 - PMC - PubMed